e-mail address: drsurcel@gmail.com
Aparitii in Presa
Dr. Cristian Surcel – Spitalul Monza, Leonard Stroe, pacient tratat prin chirurgia robotica
Chirurgie Robotica Dr. Cristian Surcel – Spitalul Monza Antena 3
Dr. Cristian Surcel – Inregistrare “Ce se intampla doctore?” PRO TV 16 06 2017
Cancerul poate fi invins, Pretuieste Viata, 24 aprilie 2016, TVR cu Andreea Marin

“Pe măsură ce îmbătrânim, probabilitatea de a fi descoperiți cu acest tip de tumoră crește. Astfel, la vârsta de 80 de ani, aproximativ 70% dintre bărbați ajung să prezinte leziuni neoplazice. Având în vedere faptul că avansarea în vârstă presupune, din nefericire, și dezvoltarea unor boli severe, de multe ori murim cu cancer de prostată și nu de cancer de prostată”, subliniază dr. Cristian Surcel, șeful Urology Center din cadrul Spitalului Monza. Detalii: www.scoalapacientilor.ro.
—–
Cancerul de prostată poate fi determinat genetic atunci când în familie există rude care au avut această afecţiune. “Există un risc dublu de a dezvolta cancer la rudele de gradul 1. De asemenea, dacă doi-trei membri ai familiei au avut cancer de prostată, riscul este amplificat de 15 ori. În screeningul pacienţilor limita de vârstă a scăzut de la 50 la 40 de ani. Astfel, toţi aceşti pacienţi sunt luaţi mai devreme sub observaţie”, a explicat dr. Cristian Surcel, medic specialist urolog, în cadrul I.C. Fundeni.
Detalii: www.sanatateatv.ro.
Radical cystectomy with lymph node dissection (LND) is recommended for muscle-invasive bladder cancer (BCa). Retrospective studies have shown that 5-yr disease-specific survival does not exceed 66% because of the high number of patients with lymph node involvement and micrometastases at diagnosis [1] . In patients with pT2 and pT3–4 tumours, local recurrence was observed in 3–4% and 11–16%, whereas distant metastases occurred in 10–27% and 19–35%, respectively [2] . In the early 1980s, median survival in untreateted was…
Detalii: www.europeanurology.com.
—–
Retrospective series and population-based data suggest that the use of local treatment of the prostate in patients with primary metastatic prostate cancer may improve cancer-specific survival and overall survival compared with treating these patients with androgen deprivation therapy alone.
Local treatment appears to improve oncologic outcomes in metastatic prostate cancer patients. Nevertheless, due to the lack of high-quality evidence, its role needs to be confirmed in future prospective trials. The selection of ideal candidates…
Detalii : link.springer.com/article.
——
Most prostate cancers (PC) are currently found on the basis of an elevated PSA, although this biomarker has only moderate accuracy. Histological confirmation is traditionally obtained by random transrectal ultrasound guided biopsy, but this approach may underestimate PC. It is generally accepted that a clinically significant PC requires treatment, but in case of an non-significant PC, deferment of treatment and inclusion in an active surveillance program is a valid option. The implementation of…
Detalii: www.ncbi.nlm.nih.gov/.
—–
“Despite the growth of the digital era, rapid spread of information, and real-time communication, there are several urologists throughout the world who do not have access to urological scientific programs, academic training programs, or memberships to well-established urological organizations, associations, and societies. The International Young Urological Association (IYUA) is a non-profit organization that was created to specifically address and facilitate access for urologists that for geopolitical, economical, or other reasons would not otherwise have these opportunities available to them.
Detalii: http://www.canjurol.com/abstract.php.
—–
In total, 59 articles reporting on the effect of NED on oncologic outcomes have been selected. In clinical practice, immunostaining for NED markers could have interesting predictive value for assessing the oncologic outcomes in patients receiving androgen-deprivation therapy. Thus, patients with high NED burden may be candidates for more aggressive treatment strategies targeting NED pathways. Conversely, strong evidence is lacking concerning its potential independent prognostic value in hormone-naïve PCa.
Current published data are not sufficient to recommend the use of NE markers in routine practice, particularly at early PCa stage.”
Detalii: www.urologiconcology.org/article/.
—–

Of the 12 850 invited EAU members, 585 urologists practising in Europe completed the survey. High-risk PCa was defined as serum PSA ≥20 ng/mL or clinical stage ≥ T3 or biopsy Gleason score ≥ 8 by 67% of responders, without significant geographical variations. The preferred single-imaging examinations for staging were bone scan (74%, 81% in WE and 70% in SE; P = 0.02 for both), magnetic resonance imaging (53%, 72% in WE and 40% in SE; P = 0.02 and P = 0.01, respectively) and computed tomography (45%, 60% in SE and 23% in WE; P = 0.01 for both).
Detalii: olinelibrary.wiley.com.
——
A PubMed search was conducted in December 2013 to find original articles, bibliographic reviews and series reports published in the past 15 years on idiopathic retroperitoneal fibrosis, its management and outcomes by combining terms like retroperitoneal fibrosis, periaortitis, treatment and autoimmune. A total of 89 articles were included in this review that referred strictly to IRF. We analyzed the imaging tools used for diagnostic and the decision making protocol used by physicians in the management of IRF.”
Detalii: www.ncbi.nlm.nih.gov.
—-
The risk of unfavorable prostate cancer in active surveillance (AS) candidates is nonnegligible. However, what represents an adverse pathologic outcome in this setting is unknown. We aimed at assessing the optimal definition of misclassification and its effect on recurrence in AS candidates treated with radical prostatectomy (RP).
Among patients eligible for AS treated with RP, only men with Gleason score≥4+3 or non–organ-confined disease at final pathology were at increased risk of BCR. These individuals represent the real misclassified AS patients, who can be predicted based on older age and higher PSA density.”
Detalii: www.urologiconcology.org.
——
The key of the successful renal transplantation is the ability to identify the best immunological match between donor and recipient considering the possibility ofrejection phenomenon. HLA typing plays an important role in renal transplantation and the correctly identification of HLA alleles is one of the most complex problems in molecular diagnosis. Patients may develop alloantibodies against foreign HLA molecules acquired by pregnancy, transfusion or previous allografts [1].
Renal transplantation in sensitized patients remains a significant challenge worldwide. Panel reactive antibody (PRA), produced against HLA pose a major risk factor forincreased…
Detalii aici: http://www.rjme.ro.
——
OBJETIVO: La biopsia de próstata (BP) es el patrón oro para el diagnostico de cáncer de próstata (CaP). Sin embargo, el número óptimo de muestras de la biopsia continua en debate. Comparamos los esquemas de biopsia estándar contemporánea (10-12 muestras) y de saturación (≥18 muestras) tanto en biopsia inicial como en biopsias repetidas.
METODOS: Realizamos una revisión no sistemática de la literatura desde el año 2000 al 2013. Evaluamos los estudios comparativos entre el esquemas estándar y la saturación…
Detalii: aeurologia.com.
——
The final pathologic Gleason score was 3+3 = 6 in 8%, 3+4 = 7 in 67%, 4+3 = 7 in 20%, and 8 to 10 in 5% cases. The overall rate of unfavorable disease (upgrading or advanced stage or both) was 46%. In multivariable analysis, prostate-specific antigen (PSA) level>10 ng/ml, PSA density (PSAD) >0.15 ng/ml/g, clinical stage >T1, and>2 positive cores were predictors of unfavorable disease. According to the AS criteria used, the risk of unfavorable disease ranged from 30% to 42%. In patients without any risk factor (PSA level≤10 ng/ml, PSAD ≤0.15 ng/ml/g, T1c, and≤2 positive cores), the unfavorable disease rate was 19%. The main limitations of this study are…
Detalii: www.urologyoncology.com.
—-
Tuberculosis of the penis represents an uncommon disease, especially in the European Countries, since the introduction of tuberculostatics [1].
It may be presented as an extrapulmonary form of tuberculosis, or, in rare cases, as primary lesion of the gland after contact with female genital ulcers [2, 3].
The main differential diagnosis of this entity is with penile cancer, by performing a biopsy of the lesion [4].
However, is not always easy to differentiate between these two entities, especially in cases with previous scrotal interventions.
Here we present a case of primary penile tuberculosis…
Detalii: www.rjme.ro.
—–
„În urologie nu există un centru mai important decât Fundeni la nivel european şi nu există procedură chirurgicală care se face în străinătate şi nu se realizează şi la noi. În fiecare an operăm 300 de pacienţi cu tumori în diverse stadii, în timp ce în orice alt spital european sunt maximum 50 de astfel de operaţii pe an. În Anglia, pacienţii stau şi şase luni pe lista de aşteptare şi, între timp, unii mai şi mor. În România, pacientul se internează azi şi mâine e operat”, explică Dr. Cristian Surcel. Pacienţii veniţi din ţări precum Italia sau Austria…
Detalii aici: romanialibera.ro.
Jun 4 / Posted by drsurcel
Jun 4 / Posted by drsurcel
Jun 4 / Posted by drsurcel